LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells

Reprod Fertil Dev. 1989;1(4):281-8. doi: 10.1071/rd9890281.

Abstract

We have previously characterized, purified and cloned a novel murine and human regulator [leukaemia inhibitory factor, LIF] which induces the differentiation of certain murine and human myeloid leukaemic cells. Recently we have shown that there are specific LIF receptors on murine embryonic stem [ES] and embryonal carcinoma [EC] cells and that purified recombinant LIF can substitute for feeder cells and crude sources of differentiation inhibiting activity [DIA] [such as BRL-cell-conditioned medium] in the maintenance of ES cells in a pluripotential state in vitro. Furthermore, ES cells maintained in culture in recombinant LIF for a prolonged period can give rise to germline chimaeric mice. Thus, based on a number of biochemical and biological similarities, it is likely that LIF and DIA are the same molecule. The identification of LIF as a molecule, necessary and sufficient for the maintenance of ES cells in culture, should have a profound impact on the use of these cells for genetic manipulations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Embryo, Mammalian
  • Embryonal Carcinoma Stem Cells
  • Growth Inhibitors / pharmacology*
  • Humans
  • Interleukin-6*
  • Leukemia Inhibitory Factor
  • Leukemia, Myeloid / pathology*
  • Lymphokines*
  • Mice
  • Molecular Sequence Data
  • Neoplastic Stem Cells / drug effects
  • Recombinant Proteins / pharmacology
  • Sequence Homology, Nucleic Acid
  • Stem Cells / drug effects*

Substances

  • Growth Inhibitors
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Lif protein, mouse
  • Lymphokines
  • Recombinant Proteins